Microbiologist Dr. Fiona Smaill, left, and her colleagues at McMaster University in Hamilton have developed an inhaled COVID-19 vaccine based on their tuberculosis vaccine research.
Margaret McCuaig-Johnston, a former federal public servant who negotiated Canada-China science and technology agreements, said the CanSino-McMaster vaccine arrangement may turn out to be "a case study of what not to do in partnerships with China." McMaster, as well, inked a licensing deal for its tuberculosis vaccine with CanSino more than a decade ago. However, the partnership hasn't been active in years.
After the deal fell apart, Prime Minister Justin Trudeau told reporters that the reason Canada partnered with CanSino was because of the "well-established partnership" between scientists in Canada and China "that has been effective in the past."McMaster scientists developed a tuberculosis vaccine in 2011 and licensed its global marketing rights to CanSino.
Education Education Latest News, Education Education Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Source: CTVNews - 🏆 1. / 99 Read more »